Table 4.
Other asthma treatments prescribed to patients in the SABINA III Philippines cohort in the previous 12 months (N=245)
| All (N=245) | Primary Care (n=90) |
Pulmonary Medicine Specialists (n=155) |
|||||
|---|---|---|---|---|---|---|---|
| Investigator-classified mild asthma (n=42) | Investigator-classified moderate-to-severe asthma (n=48) | All (n=90) | Investigator-classified mild asthma (n=48) | Investigator-classified moderate-to-severe asthma (n=107) | All (n=155) | ||
| Patients prescribed ICS, n (%) | |||||||
| Yes | 6 (2.4) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 6 (5.6) | 6 (3.9) |
| No | 239 (97.6) | 42 (100.0) | 48 (100.0) | 90 (100.0) | 48 (100.0) | 101 (94.4) | 149 (96.1) |
|
| |||||||
| Total daily ICS dose prescribed, n (%) | |||||||
| Low dose | 4 (66.7) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 4 (66.7) | 4 (66.7) |
| Medium dose | 1 (16.7) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (16.7) | 1 (16.7) |
| High dose | 1 (16.7) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1 (16.7) | 1 (16.7) |
| Total | 6 | 0 | 0 | 0 | 0 | 6 | 6 |
|
| |||||||
| Number of canisters or inhalers per patient prescribed in the previous 12 months before study visit | |||||||
| Number of patients | 6 | 0 | 0 | 0 | 0 | 6 | 6 |
| Mean (SD) | 1.0 (0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 1.0 (0.0) | 1.0 (0.0) |
| Median (min, max) | 1.0 (1.0, 1.0) | 0 (0, 0) | 0 (0, 0) | 0 (0, 0) | 0 (0, 0) | 1.0 (1.0, 1.0) | 1.0 (1.0,1.0) |
|
| |||||||
| Patients prescribed ICS/LABA (fixed-dose combination), n (%) | |||||||
| Yes | 156 (63.7) | 2 (4.8) | 48 (100.0) | 50 (55.6) | 1 (2.1) | 105 (98.1) | 106 (68.4) |
| No | 89 (36.3) | 40 (95.2) | 0 (0.0) | 40 (44.4) | 47 (97.9) | 2 (1.9) | 49 (31.6) |
|
| |||||||
| Total daily ICS dose prescribed, n (%) | |||||||
| Low dose | 67 (43.2) | 2 (100.0) | 30 (63.8) | 32 (65.3) | 1 (100.0) | 34 (32.4) | 35 (33.0) |
| Medium dose | 32 (20.6) | 0 (0.0) | 11 (23.4) | 11 (22.4) | 0 (0.0) | 21 (20.0) | 21 (19.8) |
| High dose | 56 (36.1) | 0 (0.0) | 6 (12.8) | 6 (12.2) | 0 (0.0) | 50 (47.6) | 50 (47.2) |
| Missing data | 1 | 0 | 1 | 1 | 0 | 0 | 0 |
| Total | 155 | 2 | 47 | 49 | 1 | 105 | 106 |
|
| |||||||
| Patients prescribed OCS burst/short-course OCS treatment, n (%) | |||||||
| Yes | 85 (34.7) | 14 (33.3) | 9 (18.8) | 23 (25.6) | 7 (14.6) | 55 (51.4) | 62 (40.0) |
| No | 160 (65.3) | 28 (66.7) | 39 (81.2) | 67 (74.4) | 41 (85.4) | 52 (48.6) | 93 (60.0) |
|
| |||||||
| Patients prescribed OCS long-term/OCS maintenance treatment, n (%) | |||||||
| Yes | 16 (6.5) | 0 (0.0) | 1 (2.1) | 1 (1.1) | 0 (0.0) | 15 (14.0) | 15 (9.7) |
| No | 229 (93.5) | 42 (100.0) | 47 (97.9) | 89 (98.9) | 48 (100.0) | 92 (86.0) | 140 (90.3) |
ICS, inhaled corticosteroids; LABA, long-acting β2-agonist; max, maximum; min, minimum; OCS, oral corticosteroids; SD, standard deviation